Comment on: Evolution of multiple sclerosis in France since the beginning of hepatitis B vaccination
Immunol Res
.
2015 May;62(1):1-2.
doi: 10.1007/s12026-015-8627-3.
Authors
Alfred Spira
1
,
Pierre Bégué
,
André Aurengo
Affiliation
1
Académie nationale de Médecine, Paris, France, freddyspira@gmail.com.
PMID:
25690885
DOI:
10.1007/s12026-015-8627-3
No abstract available
Publication types
Letter
Comment
MeSH terms
Hepatitis B Vaccines / immunology*
Humans
Multiple Sclerosis / epidemiology*
Multiple Sclerosis / etiology*
Substances
Hepatitis B Vaccines